Ballentine Partners »

Unity Biotechnology shares owned by Ballentine Partners

Quarter-by-quarter ownership of Unity Biotechnology (UBX) shares owned by Ballentine Partners from 13F filings

Historical chart of Ballentine Partners investment in Unity Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Unity Biotechnology held by Ballentine Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unity Biotechnology by Ballentine Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $84k 57k 1.47

More positions owned by Ballentine Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Core Msci Emkt (IEMG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Ballentine Partners

Top funds holding Unity Biotechnology

Arch Venture Corp
Alyeska Investment Group
Vanguard Group
Geode Capital Management
Citadel Advisors
Mayo Clinic
Renaissance Technologies
BlackRock
BlackRock
Ballentine Partners
Morgan Stanley
Founders Fund V Management
Cercano Management
State Street Corporation
Bridgeway Capital Management

View all funds holding Unity Biotechnology